The role of murine models in the development of antifungal therapy for systemic mycoses

Authors
Citation
Jr. Graybill, The role of murine models in the development of antifungal therapy for systemic mycoses, DRUG RESIST, 3(6), 2000, pp. 364-383
Citations number
235
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG RESISTANCE UPDATES
ISSN journal
13687646 → ACNP
Volume
3
Issue
6
Year of publication
2000
Pages
364 - 383
Database
ISI
SICI code
1368-7646(2000)3:6<364:TROMMI>2.0.ZU;2-5
Abstract
Animal testing is crucial to the development of new antifungal compounds. T his review describes the role that murine and other animal models have play ed in the development of three classes of antifungal agents: the polyenes, the triazoles and the echinocandins and the ways in which these models have been either the positive link in the path from in vitro studies to the pat ient, or have foreclosed later clinical evaluation. Efficacy studies in par ticular mycoses are discussed, as well as studies designed to determine whe ther combinations of antifungal drugs may have value over single agents. (C ) 2000 Harcourt Publishers Ltd.